Stevens Capital Management’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Stevens Capital Management’s Portfolio VTAE Stock Details VTAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-379,030	Closed	-$7.93M	–	1246
2016 Q3	$7.93M	Buy	+379,030	New	+$4.37M	0.33%	80

Stevens Capital Management's VTAE Position: Q4 2016 in Review

Stevens Capital Management sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 379,030 shares — an estimated $7.93M sold.

Stevens Capital Management first reported a position in VTAE in Q3 2016 and held it in 1 quarter. The position peaked at $7.93M in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

Stevens Capital Management reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
Stevens Capital Management sold 379,030 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $7.93M.
Stevens Capital Management first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q3 2016 and held it in 1 quarter.
Stevens Capital Management's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $7.93M in Q3 2016.
0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on Stevens Capital Management's 13F filing for Q4 2016, filed 7 Feb 2017.